Ann Clin Microbiol 2025;28(3):12. Clinical impact of the coronavirus disease 2019 pandemic on the quality of pulmonary tuberculosis management with national reimbursement data in Korea: a retrospective cohort study

Table 1. Analysis of the treatment discontinuation
FactorsEntire periodInitial intensive care periodMaintenance treatment period
βPβPβP
Intercept-0.5190 -2.3590 -1.5494 
Time factor (Trend over time)-0.0084< 0.0001-0.00710.0121-0.00760.0001
Before and during pandemic phase of COVID-19 (Level change)-0.01660.66950.00750.90630.01030.8142
Intersection term (Slope change)0.00390.14810.00150.74130.0040.1949

Bold forms: statistically significant.
Abbreviation: COVID-19, coronavirus disease 2019.